Compound Summary
Compound Information
neostigmine bromide
Compound Name: | neostigmine bromide |
Compound CID: | 8246 |
Synonyms: | neostigmine bromide 114-80-7 Eustigmin bromide Neoserine bromide neo-Proserin More... |
Iupac Name: | [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium;bromide |
InChI: | InChI=1S/C12H19N2O2.BrH/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;/h6-9H,1-5H3;1H/q+1;/p-1 |
InChIKey: | LULNWZDBKTWDGK-UHFFFAOYSA-M |
Canonical Smiles: | CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.[Br-] |
Isomeric Smiles: | CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.[Br-] |
Molecular Weight: | 303.2 |
Molecular Formula: | C12H19BrN2O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
neostigmine bromide
Molecular Weight: | 303.2 |
Molecular Formula: | C12H19BrN2O2 |
Hydrogen Bond Donor Count: | 0 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 17 |
Complexity: | 246 |
Synonyms
neostigmine bromide
| neostigmine bromide | neostigmine bromide |
|---|---|
neostigmine bromide |
114-80-7 |
Eustigmin bromide |
Neoserine bromide |
neo-Proserin |
Proserine bromide |
Stigmanol bromide |
Synstigmin bromide |
Leostigmine bromide |
Kirkstigmine bromide |
Philostigmin bromide |
Prostigmin |
3-((Dimethylcarbamoyl)oxy)-N,N,N-trimethylbenzenaminium bromide |
Neostigmine methyl bromide |
Neostigmini bromidum |
Vagostigmin |
Bromure de neostigmine |
Bromuro de neostigmina |
Neostigmine (Bromide) |
UNII-005SYP50G5 |
3-(dimethylcarbamoyl)oxy-N,N,N-trimethylanilinium bromide |
3-Dimethylcarbamoxyphenyl trimethyl ammonium bromide |
114-80-7 (bromide) |
MLS000028387 |
3-(dimethylcarbamoyloxy)phenyl-trimethylazanium;bromide |
(m-Hydroxyphenyl)trimethylammonium bromide dimethylcarbamate |
3-Hydroxyphenyltrimethylammonium bromide dimethylcarbamic ester |
CHEBI:179557 |
005SYP50G5 |
Eustigmin bromide;Neoserine bromide |
MFCD00011795 |
SMR000058591 |
Stigmosan bromide |
Prostigmin bromide |
DSSTox_CID_21075 |
DSSTox_RID_79621 |
Prostigmine bromide |
DSSTox_GSID_41075 |
Synstigmini bromidum |
Syntostigmin bromide |
Vagostigmine bromide |
Syntostigmine bromide |
3-(Dimethylcarbamoyloxy)trimethylanilinium ion Bromatum |
Synthostigmine bromide |
Syntostigmin (tablet) |
Synstigminbromid |
3-(N,N-Dimethylcarbamoyloxy)-N,N,N,-trimethylanilinium bromide |
Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-, bromide |
Benzenaminium, 3-(dimethylamino)carbonyloxy-N,N,N-trimethyl-, bromide |
Neostigmina bromuro |
Neostigmina bromuro DCIT |
Neostigmini bromidum INN-Latin |
SR-01000000073 |
NCGC00163240-01 |
CAS-114-80-7 |
EINECS 204-054-8 |
Bromure de neostigmine INN-French |
Bromuro de neostigmina INN-Spanish |
Neo proserine |
Vagostigmin (TN) |
Prestwick_352 |
Neostigmine bromide USP:INN:BAN:JAN |
NEOSTIGMINEBROMIDE |
Opera_ID_1504 |
Carbamic acid, dimethyl-, ester with (m-hydroxyphenyl)trimethylammonium bromide |
SCHEMBL41128 |
MLS001146913 |
CHEMBL54126 |
SPECTRUM1500428 |
DTXSID9041075 |
Neostigmine bromide (Prostigmin) |
HMS500I07 |
HMS1569M18 |
HMS1920P15 |
HMS2091H18 |
HMS2096M18 |
HMS2235J11 |
HMS3262D13 |
HMS3372E02 |
HMS3713M18 |
Pharmakon1600-01500428 |
ACT05638 |
HY-B0423 |
Neostigmine bromide (JAN/USP/INN) |
Tox21_112037 |
Tox21_500816 |
CCG-39110 |
NSC757233 |
s2490 |
AKOS015895725 |
AMMONIUM, (m-HYDROXYPHENYL)TRIMETHYL-, BROMIDE, DIMETHYLCARBAMATE |
Tox21_112037_1 |
LP00816 |
MCULE-9726153183 |
NSC 757233 |
NSC-757233 |
NCGC00015730-11 |
NCGC00094149-01 |
NCGC00094149-02 |
NCGC00094149-03 |
NCGC00094149-04 |
NCGC00261501-01 |
BS-14646 |
Q562 |
MLS-0002855.P042 |
AB0004770 |
EU-0100816 |
FT-0651572 |
N0358 |
ST50411544 |
C08197 |
C71473 |
D00995 |
N 2001 |
A803245 |
SR-01000000073-3 |
SR-01000000073-5 |
SR-01000000073-7 |
W-108598 |
(3-Dimethylcarbamoyloxyphenyl)trimethylammonium Bromide |
Q27105147 |
N,N-dimethyl3-(trimethylamino)phenoxycarboxamide, bromide |
Neostigmine bromide, >=98% (HPLC and titration), powder |
(3-Hydroxyphenyl)trimethylammonium Bromide Dimethyl Carbamate |
3-dimethylamino(oxo)methoxyphenyl-trimethylammonium bromide |
Neostigmine bromide, European Pharmacopoeia (EP) Reference Standard |
Neostigmine bromide, United States Pharmacopeia (USP) Reference Standard |
Experimental Data
neostigmine bromide
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -11 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
neostigmine bromide
Statistics Data
neostigmine bromide
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -11 | 1 | 1 |
Statistics Data Visualization
neostigmine bromide
